IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Portfolio Profile

CIK: 0001703031 | Boston, MA

Investment Profile

Style

GARP

Turnover

Medium

Orientation

Concentrated trader
$1.7B
AUM
21
Positions
87.85%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Kailera Therapeutics Inc(KLRA)22,583,268$497.5M29.58%
2Heartflow Inc(HTFL)8,448,158$247.9M14.74%
3Newamsterdam Pharma Company(NAMS)3,806,566$129.0M7.67%
4Savara Inc(SVRA)17,600,621$108.4M6.45%
5Alkermes PLC(ALKS)1,937,938$101.5M6.04%
6

Sector Allocation

Latest filing, equity positions only

Healthcare53.14% · $893.9M
Unclassified46.86% · $788.1M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare71.41%53.14%-18.27%
Unclassified28.59%46.86%+18.27%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$894.2M | 31 pos.
$1.0B | 27 pos.
$1.2B | 26 pos.
$910.8M | 25 pos.
$961.2M | 24 pos.
$850.1M | 26 pos.
Solid Biosciences Inc(SLDB)
9,808,819
$98.0M
5.83%
7Pharvaris N V(PHVS)2,675,509$92.5M5.50%
8Olema Pharmaceuticals Inc(OLMA)7,085,249$88.6M5.27%
9Hemab Therapeutics Holdings Inc(COAG)1,650,000$60.6M3.60%
10Cabaletta BIO Inc(CABA)17,241,445$53.6M3.19%
Cap SizePrev %Curr %Change
Unclassified28.59%46.86%+18.27%
Small Cap34.93%23.61%-11.32%
Mid Cap30.7%23.49%-7.21%
Micro Cap5.78%6.05%+0.27%
$675.9M | 24 pos.
$799.3M | 23 pos.
$1.5B | 21 pos.
$1.3B | 19 pos.
$1.1B | 20 pos.
$1.7B | 21 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

2
New
1
Closed
2
Increased
7
Decreased
10
Unchanged